论文部分内容阅读
本文对当前心力衰竭的病理生理和流行病学认识基础上,,综述了慢性心力衰竭的基础研究和临床药物治疗进展。心衰合并心电学异常的患者中,近来短期和长期研究发现应用心脏起搏可使心脏活动再同步,改善心功能,提高生活质量和生存率,认为心脏再同步化疗法是严重心衰合并心电学异常患者的一种理想的非药物辅助治疗选择。
This article based on the current understanding of pathophysiology and epidemiology of heart failure, reviewed the basic research and clinical drug treatment of chronic heart failure. Short-term and long-term studies of short-term and long-term studies of patients with heart failure and electrocardiogram have recently found that cardiac pacing can be used to resynchronize cardiac activity, improve cardiac function, and improve quality of life and survival rates. Cardiac resynchronization chemotherapy is considered as severe heart failure combined with heart failure An ideal non-drug adjuvant treatment option for patients with electrical abnormalities.